Skip to main content

Table 1 Clinical characteristic of included studies (49 prevalence studies)

From: Prevalence and risk factors related to poor outcome of patients with severe Plasmodium vivax infection: a systematic review, meta-analysis, and analysis of case reports

Major complication (WHO, 2014) Total patients with severity sign Severity rate (%)
Total P.vivax, 42,325 cases
Respiratory distress 566 1.34
Acidosis 44 0.10
Pulmonary edema 126 0.30
Death 152 0.36
Cerebral malaria 471 1.11
Convulsion 75 0.18
ARF 355 0.84
Prostration 26 0.06
Hypotension/shock 267 0.63
Jaundice 634 1.50
Severe anemia 1001 2.37
Bleeding/DIC 242 0.57
Hyperparasitemia 31 0.07
Hypoglycemia 65 0.15
Minor complication
 Hyperpyrexia 57 0.13
 Severe vomiting 139 0.33
 Drowsiness 123 0.29
 Hepatitis 308 0.73
 Respiratory (NS*) 1 0.00
 Severe vomiting 1 0.00
 Sudden cardiac arrest 7 0.02
 Hemoglobinuria/Hematuria 143 0.34
 Anemia 1008 2.38
 Thrombocytopenia 1243 2.94
  1. *NS Not specified